Neurotech Startup JuneBrain Just Landed $10M—What This Means for Your Brain Health!

Baltimore-based neurotechnology startup JuneBrain is making headlines with its innovative approach to diagnosing and monitoring neurological diseases. Recently, the company secured a joint investment from the New Orleans BioFund and the Gulf South Angels (GSA) to advance its pioneering work in neurological disease detection, particularly for conditions like multiple sclerosis, Parkinson's, and Alzheimer's. The funding comes at a time when early detection and intervention are critical for improving patient outcomes in the realm of neurological health.

JuneBrain’s flagship product is a portable headset that employs AI-powered optical coherence tomography (OCT). This cutting-edge technology allows for remote monitoring of eye and neurological symptoms, offering real-time insights that can be crucial for timely diagnosis and treatment. The emphasis on early detection is supported by research indicating that earlier interventions can significantly improve the long-term care of patients with these debilitating diseases.

Highlighting its promise, JuneBrain placed first in the 2025 BioChallenge Pitch Competition powered by the New Orleans BioInnovation Center (NOBIC). This accolade not only bolsters the company’s credibility but also underscores the growing life sciences ecosystem in Louisiana. The investment from The New Orleans BioFund and Gulf South Angels will facilitate the acceleration of JuneBrain's development and expand access to its technology throughout the region.

A Growing Ecosystem in Louisiana

The significance of this investment extends beyond JuneBrain. It reflects a broader trend in the Gulf South, where a vibrant life sciences community is emerging. As more startups and investors focus on health technologies, Louisiana is positioning itself as a hub for innovation in the medical field. The collaboration between JuneBrain and local healthcare systems and universities is a testament to the potential of strategic partnerships to accelerate growth in this sector.

Kris Khalil, Managing Director of The New Orleans BioFund, commented on the investment, saying,

“JuneBrain represents exactly the kind of company BioChallenge was built to champion, a team using cutting-edge AI to solve a real clinical gap in how we detect and monitor neurological disease. We believe this technology can change patient outcomes at scale. We will improve patient outcomes and build a strong life sciences economy in Louisiana one bold investment at a time.”

Mike Eckert, Board Chairman of the Gulf South Angels, echoed Khalil’s enthusiasm, noting that the organization was “impressed by JuneBrain's combination of breakthrough technology and strong market potential.” He added, “Investments like this reflect our commitment to supporting high-potential companies and partnering with organizations like NOBIC to bring innovative ventures into the Gulf South's expanding entrepreneurial ecosystem.”

Looking toward the future, Dr. Samantha Scott, the founder of JuneBrain, expressed gratitude for the support received from the local startup community. She stated,

“From our experience at BioChallenge to the ongoing support from GSA and NOBIC, the New Orleans startup community has welcomed us with open arms. This funding allows us to accelerate development, expand access to our technology, and continue building meaningful roots in Louisiana as we grow.”

As JuneBrain continues to forge ahead with its technological advancements, the implications for patients suffering from neurological conditions are profound. The potential for enhanced monitoring could lead to timely interventions and improved care pathways, ultimately affecting countless lives. Moreover, as more resources are directed toward health tech innovations in Louisiana, the state could very well emerge as a leader in the field of neurological health.

In summary, JuneBrain’s cutting-edge neurotech solutions, supported by strategic investments from local organizations, stand to transform the landscape of early detection and monitoring of neurological diseases. This not only promises to enhance patient outcomes but also contributes to the burgeoning life sciences ecosystem in Louisiana, marking a significant leap forward in healthcare innovation.